Loading page
Loading page
Loading substance route
Confusion has been reported as an acute effect. One case at 4 mg produced substantial amnesia and a state of relative hibernation lasting several hours, though explicit psychotic symptoms have not been documented.
ALEPH-2 was first introduced to the scientific literature by Alexander Shulgin in 1978 as part of his systematic exploration of phenethylamine derivatives. The compound belongs to the Aleph series, a family of sulfur-substituted psychedelic amphetamines that Shulgin developed and characterized.…
Not classified as a controlled substance at the federal level as of 2011. As an unscheduled compound, possession is not specifically prohibited under the Controlled Substances Act. However, as a structural analogue of controlled phenethylamines, the Federal Analogue Act may potentially apply if the substance is sold or possessed with intent for human consumption.
19 sources cited